Actively Recruiting
ASCENT Intervention for Brain Tumor Patients
Led by Massachusetts General Hospital · Updated on 2025-07-14
100
Participants Needed
1
Research Sites
219 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to refine and test a psychosocial intervention called ASCENT (ACT-based Supportive intervention for patients with CENTral nervous system tumors). This intervention was developed to help patients after being diagnosed with a brain tumor. The main question this study aims to answer is whether this intervention is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in 6 coaching sessions and complete short surveys at four different time points. Some participants will be asked to share feedback via interviews.
CONDITIONS
Official Title
ASCENT Intervention for Brain Tumor Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 218
- Patient at Massachusetts General Hospital Cancer Center
- Diagnosed with malignant primary Central Nervous System tumor within 6 months
- English speaking
You will not qualify if you...
- Unable to provide informed consent due to severe cognitive impairment or dementia
- Moderate to severe receptive aphasia
- Currently enrolled or about to enroll in hospice
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
D
Deborah A Forst, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here